6.03
price down icon0.99%   -0.06
after-market Dopo l'orario di chiusura: 6.08 0.05 +0.83%
loading

Cullinan Therapeutics Inc Azioni (CGEM) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
37.82%
75.80
55.00 48.85 50.03 42.99
Operating Income/Loss
37.82%
-75.80
-55.00 -48.85 -50.03 -42.99
Income/Loss From Continuing Operations Before Tax
44.44%
-70.06
-48.50 -40.56 -42.03 -37.34
Income/Loss From Continuing Operations After Tax
44.44%
-70.06
-48.50 -40.56 -42.03 -37.34
Net Income/Loss
44.44%
-70.06
-48.50 -40.56 -42.03 -37.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -0.192
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.77
price down icon 1.30%
$84.16
price down icon 0.45%
$29.45
price up icon 2.51%
$99.75
price up icon 1.51%
$141.00
price down icon 3.01%
biotechnology ONC
$329.84
price up icon 0.23%
Capitalizzazione:     |  Volume (24 ore):